Clodronate is effective in preventing corticosteroid-induced bone loss among asthmatic patients (Q74587810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Clodronate is effective in preventing corticosteroid-induced bone loss among asthmatic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

H Puolijoki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

K Liippo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M Raitio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

O Impivaara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

E Tala

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M M Nieminen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

577-582

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

Steroid-induced fractures and bone loss in patients with asthma

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Absorption of oral diphosphonate in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Secondary Hyperparathyroidism Associated with Dichloromethane Diphosphonate Treatment of Paget's Disease*

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Epidemiology and clinical features of osteoporosis in young individuals

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Dual-energy X-ray absorptiometry in normal women: a cross-sectional study of 717 Finnish volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Bone mineral density measured by dual-energy X-ray absorptiometry in healthy Finnish women.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

New perspectives on inhaled drug delivery and systemic bioactivity

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Bone loss in response to long-term glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Etidronate in the management of glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Clodronate treatment in patients with malignancy-associated hypercalcemia

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Two-year follow-up of biphosphonate (APD) treatment in steroid osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

The effects of dichloromethylene biphosphonate on osteoporotic femora of adult castrate male rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

Clodronate kinetics and bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2898%2900051-9

7 January 2021

10.1016/S8756-3282(98)00051-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9600795%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference